Evidence map›Paper›PMID 42182939›Full record

ArticleJournal of clinical biochemistry and nutrition2026

A rank-based robust change-point regression approach in human intervention studies of functional foods.

Kohsuke Hayamizu

Abstract read
In one paragraph

Article in Journal of clinical biochemistry and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kohsuke HayamizuFaculty of Pharmaceutical Sciences, Yokohama University of Pharmacy, Matano-cho 601, Totsuka-ku, Yokohama, Kanagawa 245-0066, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterogeneity of treatment effects is common in functional-food studies, particularly when baseline characteristics influence the magnitude of response. Change-point regression models (CPRM) are useful for identifying the baseline level at which an intervention effect begins to appear. However, conventional CPRM relies on ordinary least squares (OLS-CPRM) and is sensitive to outliers, which can lead to unstable estimation of the change point (τ). To address this issue, I developed a rank-based robust CPRM (RR-CPRM) and evaluated its utility using two clinical datasets. RR-CPRM produced estimates of τ consistent with those of the conventional model while providing narrower bootstrap confidence intervals, indicating improved stability and reduced sensitivity to outliers. In datasets with little to no influence from outliers, RR-CPRM yielded results comparable to OLS-CPRM, demonstrating that robustness is achieved without loss of performance. These findings suggest that RR-CPRM offers a reliable and flexible framework for evaluating baseline-dependent intervention effects in human functional-food trials and may contribute to more accurate interpretation of clinical outcomes.

Indexed as

change-point regression modelfunctional foodshuman intervention studyrank-based methods

Identifiers

PMID42182939
PMCPMC13193799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.